The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'May 2020'. If you still can't find what you are looking for, try using the search box.
An experienced public and private company Non-Executive Director, Peter has sat on over 30 boards during his career. He is currently a Director of Endomagnetics Ltd, a company improving cancer surgery outcomes; and the medical charity LifeArc which has assets significantly in excess of £1bn following the monetisation of the leading cancer drug Keytruda.
Read the rest of entry »
Business Development Manager for TBAT’s Oxford Office, Vincent Seddon, has cleared his diary for 1 day to book one-to-one consultations, to discuss R&D funding opportunities for your business!
Research Triangle Park, NC, USA and Cambridge, UK, 26 May 2020 -- Inivata, a leader in liquid biopsy, today announces the formation of a strategic collaboration with NeoGenomics, Inc (NASDAQ: NEO), for the commercialization of its InVisionFirst®-Lung liquid biopsy test in the United States.
Don't miss this month's OBN Newsletter - despite the COVID-19 Crisis there has been so much going on with OBN including:
This webinar is part of a complimeny series provided by RSSL and hosted by Dr Tim Sandle.
These webinars are designed to guide you through the complexities around sterile products manufacturing, control, testing and release.
Over the last few weeks and months, I have read and posted so much positive news about the involvement of Oxford University in the race to successfully develop a vaccine for COVID-19. I wanted to pull my learnings together in this article which I hope highlights just how well the teams at Oxford are doing as I am so incredibly proud of all of the good work. This is not meant to be a scientific in-depth analysis as I am not a specialist in this field, but I hope that you understand why I feel compelled to write this and you also feel pride in our team here on Oxfordshire soil. #oxford #biotech #biopharmaceutical
Sandwich, Kent, May 13 2020 - The Life sciences and healthcare community at Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, is working to tackle the coronavirus pandemic in a variety of ways.
AMSBIO has extended its COVID-19 research portfolio with the introduction of a service to provide custom lentivirus pseudotyped with spike glycoprotein from SARS-CoV-2 to help researchers identify potential targets for development of therapeutic drugs and vaccines.
On 23rd April 2020, we watched an online broadcast from Barclays which served as an update and Q&A regarding the new billion-pound initiative from the UK Government to support innovative businesses.
In response to the COVID-19 outbreak, A4P Bio Logistics has collaborated with Wren Healthcare to offer a one-stop solution for CRO’s, sponsors and study sites to support the continuation of clinical trial studies through home nursing and direct-to-patient IMP and sample logistics
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.